RESUMEN
OBJECTIVE: The aim of this study was to compare estimates of the prevalence and incidence of metabolic syndrome (MetS) using various data sources. METHODS: We integrated health risk assessment (HRA), claims, and biometric screening data from Lockheed Martin Corporation. We measured the extent to which MetS risk factors measured using HRA and medical claims correlated with biometric screening data. RESULTS: Using biometric data, 24.9% of employees were identified as having MetS. Prevalence estimates were much lower using HRA data (6.8%) and claims (3.7%). Between 2012 and 2014, 10.4% of the sample newly acquired MetS. The number of MetS risk factors per employee was predictive of diabetes, heart disease, health care costs, and utilization. CONCLUSION: MetS is prevalent and associated with progression to disease. It is more easily tracked with biometric screening data than with HRA or claims data. Employers should consider efforts to manage and prevent this condition in their workforce.
Asunto(s)
Reclamos Administrativos en el Cuidado de la Salud/estadística & datos numéricos , Antropometría , Industria Manufacturera , Síndrome Metabólico/epidemiología , Medición de Riesgo/estadística & datos numéricos , Aeronaves , Glucemia/metabolismo , Estatura , Peso Corporal , Bases de Datos Factuales , Diabetes Mellitus/epidemiología , Femenino , Recursos en Salud/economía , Recursos en Salud/estadística & datos numéricos , Cardiopatías/epidemiología , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Obesidad/epidemiología , Salud Laboral , Prevalencia , Factores de Riesgo , Circunferencia de la CinturaRESUMEN
OBJECTIVE: To determine the prevalence and incidence of low back pain (LBP) among workers in the aerospace and defense industry and in a specific company. METHODS: Claims and demographic data from the Truven Health MarketScan normative database representing more than 1 million workers were drawn from a group of 18 US benchmark companies and compared with one particular company, Lockheed Martin Corporation. RESULTS: The prevalence of LBP in the MarketScan normative group was 15.6% in the final study year (2012), whereas the incidence of new cases was 7.2% and 7.3% in years 2011 and 2012, respectively. Compared with the normative group, the company's prevalence and incidence rates were lower. Women and older workers were more likely to experience LBP compared with men and younger workers. CONCLUSIONS: The analysis was used to inform the company's leadership about the health burden of the condition and evaluate alternative treatment options to prevent the incidences and reduce the prevalence of clinical back pain among workers.